课题基金 / 基金详情

SEPARATION AND CHARACTERIZATION OF ALTERED HEME PRODUCTS

SEPARATION AND CHARACTERIZATION OF ALTERED HEME PRODUCTS
改变血红素产品的分离和表征
批准号:
3770431
负责人:
A I ALAYASH
金额:
$0.0万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

A I ALAYASH的其他基金

相似基金

相关文献

中文摘要
翻译
基于血红蛋白的血液代用品毒性的潜在机制
英文摘要
One potential mechanism of toxicity of hemoglobin-based blood substitutes involves the reaction of hemoglobin with oxygen metabolites formed upon reperfusion of ischemic tissues. This could lead to a deleterious pathway in which oxidatively damaged hemoglobin releases its heme and subsequently, its toxic iron. We tested the susceptibility of a number of chemically modified hemoglobins to oxidative damage caused by hydrogen peroxide (H2O2). Treatment of hemoglobins with low levels of H2O2 produced soluble protein-bound heme products that were subsequently isolated using HPLC. Human hemoglobin cross-linked at the alpha subunits showed a typical propensity to oxidative modification than other forms of hemoglobin modifications. The heme derived adducts from the reaction of H2O2 with hemoglobins showed little or no oxidase activity in the NADPH-diaphorase methemoglobin reductase system. A similar approach is currently underway to assess the susceptibility of other hemoglobin-based red cell substitutes to oxidative damage in order to determine the molecular basis of heme and protein alterations. The potential for oxidative damage by hemoglobin solutions opens a critical field of study that will have to be well understood before any of the present generation of hemoglobin products will be successful as a reperfusion agent.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MODIFIED HEMOGLOBINS AS A SOURCE OF ACTIVATED OXYGEN SPECIES
AUTOOXIDATION AND STABILITY OF CROSSLINKED HEMOGLOBINS
FUNCTIONAL MODIFICATIONS OF SICKLE CELL ERYTHROCYTES
NITRIC OXIDE BINDING TO CROSS-LINKED HUMAN FERRIHEMOGLOBINS
海外基金